Product Name: Anti-Human CD85a/LILRB3 Antibody (SAA2377)
Biological Function:
Anti-Human CD85a/LILRB3 Antibody (SAA2377) is a highly specific and potent monoclonal antibody that targets CD85a, also known as Leukocyte Immunoglobulin-like Receptor B3 (LILRB3). CD85a is a member of the immunoglobulin superfamily and is primarily expressed on the surface of natural killer (NK) cells, monocytes, and dendritic cells. It plays a crucial role in regulating the immune response by interacting with its ligands, which are expressed on various cells, including tumor cells, infected cells, and endothelial cells.
Main Applications:
This antibody is a valuable tool for studying the role of CD85a in immune regulation and its potential as a therapeutic target. It has been extensively used in research on cancer, infectious diseases, and autoimmune disorders. Additionally, it can be used for diagnostic purposes, such as identifying CD85a expression in different cell types and tissues.
Experimental Use Cases:
1. In cancer research: CD85a has been shown to have both inhibitory and activating functions in NK cells, making it a potential target for cancer immunotherapy. Anti-Human CD85a/LILRB3 Antibody (SAA2377) can be used to investigate the role of CD85a in tumor immune evasion and to develop novel treatments targeting this receptor.
2. In infectious diseases: CD85a has been reported to modulate the immune response against various viral and bacterial infections. This antibody can be used to study the interaction between CD85a and its ligands in the context of different infections and to evaluate its potential as a therapeutic target for infectious diseases.
3. In autoimmune disorders: CD85a has been implicated in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Anti-Human CD85a/LILRB3 Antibody (SAA2377) can be used to investigate the role of CD85a in these diseases and to develop new treatment strategies.
In summary, Anti-Human CD85a/LILRB3 Antibody (SAA2377) is a valuable tool for studying the function of CD85a in immune regulation and its potential as a therapeutic target in various diseases. Its high specificity and potency make it an ideal choice for research and diagnostic purposes. Order now to advance your research in the field of immunology and beyond.
Keywords: Anti-Human CD85a/LILRB3 Antibody, SAA2377, CD85a, Leukocyte Immunoglobulin-like Receptor B3, NK cells, monocytes, dendritic cells, immune regulation, therapeutic target, cancer, infectious diseases, autoimmune disorders, tumor immune evasion, viral infections, bacterial infections, autoimmune diseases, rheumatoid arthritis, multiple sclerosis, specificity, potency, research, diagnostic, immunology.
There are no reviews yet.